Gencurix Inc. (KOSDAQ:229000)
South Korea
· Delayed Price · Currency is KRW 2,355.00
+541.00 (29.82%)
Jun 27, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis) | 2.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 196.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 5524.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostic Kits Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rental | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rental Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| South Korea | 2.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 7.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 109.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -55.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|